Published in Sci Rep on November 22, 2016
Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease. Nutrients (2017) 0.75
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature (2009) 10.59
Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab (2009) 5.02
Lipid-induced insulin resistance: unravelling the mechanism. Lancet (2010) 4.88
Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol (2012) 4.86
PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol (2009) 4.09
Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci (2010) 3.72
Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab (2011) 3.38
Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes (1991) 3.25
AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab (2010) 2.40
Hepatic triacylglycerol accumulation and insulin resistance. J Lipid Res (2008) 2.14
Decoding cell death signals in liver inflammation. J Hepatol (2013) 2.05
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med (2012) 1.87
Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase. J Biol Chem (2004) 1.86
Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology (2014) 1.81
From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol (2013) 1.75
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia. J Clin Invest (2014) 1.63
Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol (2005) 1.63
Caloric restriction increases gluconeogenic and transaminase enzyme activities in mouse liver. Exp Gerontol (2003) 1.48
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology (2013) 1.42
Fueling the flame: bioenergy couples metabolism and inflammation. J Leukoc Biol (2012) 1.26
Fructose as a key player in the development of fatty liver disease. World J Gastroenterol (2013) 1.26
Anaplerotic roles of pyruvate carboxylase in mammalian tissues. Cell Mol Life Sci (2006) 1.23
De novo lipogenesis in health and disease. Metabolism (2014) 1.20
Stimulation of pancreatic islet metabolism and insulin release by a nonmetabolizable amino acid. Proc Natl Acad Sci U S A (1981) 1.16
Short-term metabolic fate of [13N]ammonia in rat liver in vivo. J Biol Chem (1987) 1.15
Myokines in insulin resistance and type 2 diabetes. Diabetologia (2014) 1.08
Systemic activation of glutamate dehydrogenase increases renal ammoniagenesis: implications for the hyperinsulinism/hyperammonemia syndrome. Am J Physiol Endocrinol Metab (2010) 1.06
NAD⁺ in aging, metabolism, and neurodegeneration. Science (2015) 1.05
Role of mitochondria in nonalcoholic fatty liver disease--from origin to propagation. Clin Biochem (2012) 1.03
Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Semin Liver Dis (2013) 1.02
SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. Obes Surg (2009) 0.97
Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Mol Cell Endocrinol (2013) 0.96
The complex mechanism of glutamate dehydrogenase in insulin secretion. Diabetes (2011) 0.95
Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? Free Radic Res (2013) 0.94
SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK. Aging (Albany NY) (2013) 0.94
The NAD ratio redox paradox: why does too much reductive power cause oxidative stress? Toxicol Mech Methods (2013) 0.93
Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci (2014) 0.92
High protein diet induces pericentral glutamate dehydrogenase and ornithine aminotransferase to provide sufficient glutamate for pericentral detoxification of ammonia in rat liver lobules. Histochem Cell Biol (1999) 0.92
The stimulus-secretion coupling of amino acid-induced insulin release. Influence of a nonmetabolized analog of leucine on the metabolism of glutamine in pancreatic islets. J Biol Chem (1982) 0.91
Role of mitochondria in nonalcoholic fatty liver disease. Int J Mol Sci (2014) 0.91
Short-term metabolic fate of 13N-labeled glutamate, alanine, and glutamine(amide) in rat liver. J Biol Chem (1988) 0.90
Studies of hepatic glutamine metabolism in the perfused rat liver with (15)N-labeled glutamine. J Biol Chem (1999) 0.89
The role of glutamate dehydrogenase in mammalian ammonia metabolism. Neurotox Res (2011) 0.89
A mass isotopomer study of urea and glutamine synthesis from 15N-labeled ammonia in the perfused rat liver. J Biol Chem (1996) 0.88
Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux. J Biol Chem (2014) 0.86
Regulation of glutamate dehydrogenase by Mg2+ and magnification of leucine activation by Mg2+. Mol Pharmacol (1990) 0.86
The structure and allosteric regulation of glutamate dehydrogenase. Neurochem Int (2010) 0.85
Glutamate dehydrogenase: structure, allosteric regulation, and role in insulin homeostasis. Neurochem Res (2013) 0.84
Hepatocyte nuclear factor 4α regulates the expression of the murine pyruvate carboxylase gene through the HNF4-specific binding motif in its proximal promoter. Biochim Biophys Acta (2013) 0.82
Analysis of L-type amino acid transporter in canine hepatocellular carcinoma. J Vet Med Sci (2015) 0.76
Who watches the watchmen? Regulation of the expression and activity of sirtuins. FASEB J (2016) 0.76